Skip to Main Content

Author Details

Lucia L Lam
School of Clinical Medicine, University of Hong Kong, Queen Mary Hospital
2008
31
25
PMIDPaper TitleJournal TitlePublished Year
36384818Axillary Reverse Mapping in the Prevention of Lymphoedema: A Systematic Review and Pooled Analysis.Clin Breast Cancer2023
30542054Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance.Prostate Cancer Prostatic Dis2019
29185869Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.J Clin Oncol2018
28528811Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens.Eur Urol2017
28390739Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.Eur Urol2017
28358655Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease.J Clin Oncol2017
28341589Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay.J Mol Diagn2017
28881605Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients.Oncotarget2017
26058959Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.Eur Urol2016
27713863Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report.Urol Case Rep2016
27419104Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis.Res Rep Urol2016
27574020Decipher correlation patterns post prostatectomy: initial experience from 2â¿¿342 prospective patients.Prostate Cancer Prostatic Dis2016
27438142Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies.Oncotarget2016
26809071Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk.Urology2016
26806658Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy.Eur Urol2016
27105761Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures.J Urol2016
26945428Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens.J Mol Diagn2016
24158853Spread of X-chromosome inactivation into autosomal sequences: role for DNA elements, chromatin features and chromosomal domains.Hum Mol Genet2014
25456371Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.Lancet Oncol2014
25344601Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer.J Natl Cancer Inst2014
21883162Epigenetic vestiges of early developmental adversity: childhood stress exposure and DNA methylation in adolescence.Child Dev2013
24068973The molecular mechanism of a cis-regulatory adaptation in yeast.PLoS Genet2013
23667927Reply to Suderman et al.: Importance of accounting for blood cell composition in epigenetic studies.Proc Natl Acad Sci U S A2013
23770138Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population.J Urol2013
23452981Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array.Epigenetics Chromatin2013
22322129Population-specificity of human DNA methylation.Genome Biol2012
23045638Factors underlying variable DNA methylation in a human community cohort.Proc Natl Acad Sci U S A2012
21597963Chromosome-wide DNA methylation analysis predicts human tissue-specific X inactivation.Hum Genet2011
19717977Targeting of EZH2 to a defined genomic site is sufficient for recruitment of Dnmt3a but not de novo DNA methylation.Epigenetics2009
18495781Myeloid cell differentiation in response to calcitriol for expression CD11b and CD14 is regulated by myeloid zinc finger-1 protein downstream of phosphatidylinositol 3-kinase.J Leukoc Biol2008
18818693DNA methylation in ES cells requires the lysine methyltransferase G9a but not its catalytic activity.EMBO J2008
  • 1 - 31 of 31

Recommended Authors

University of Washington
Career Start Year 2014
Number of shared co-authors 10
Oregon Health & Science University
Career Start Year 2013
Number of shared co-authors 0
The Blizard Institute Queen Mary University of London London UK.
Career Start Year 2012
Number of shared co-authors 0
Geisel School of Medicine, Dartmouth College
Career Start Year 2012
Number of shared co-authors 1
Van Andel Institute
Career Start Year 2010
Number of shared co-authors 3
Departments of Bioinformatics and Clinical Genomics, Illumina Inc.
Career Start Year 2009
Number of shared co-authors 1
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 2
Maastricht University Medical Center
Career Start Year 2007
Number of shared co-authors 3
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 4
German Cancer Research Center (DKFZ)
Career Start Year 2006
Number of shared co-authors 2
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year 2005
Number of shared co-authors 0
UCL Cancer Institute, University College London
Career Start Year 2005
Number of shared co-authors 1
Geisel School of Medicine, Dartmouth College
Career Start Year 2005
Number of shared co-authors 1
University of Melbourne
Career Start Year 2005
Number of shared co-authors 5
University of St Andrews
Career Start Year 2004
Number of shared co-authors 13
Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 2
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2003
Number of shared co-authors 6
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 3
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 3
CEA-Institut de Biologie Francois Jacob, Universite Paris-Saclay
Career Start Year 2002
Number of shared co-authors 0
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 1
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 1
Dana-Farber Cancer Institute
Career Start Year 2001
Number of shared co-authors 1
David Geffen School of Medicine, University of California los angeles
Career Start Year 1998
Number of shared co-authors 4
University of Texas Health San Antonio (UTHSA)
Career Start Year 1997
Number of shared co-authors 2
Ghent University
Career Start Year 1995
Number of shared co-authors 3
Kaiser Permanente Research Bank
Career Start Year 1994
Number of shared co-authors 1
European Translational Oncology Prevention and Screening (EUTOPS) Institute
Career Start Year 1993
Number of shared co-authors 0
Barcelona Institute of Science and Technology, Spain Universitat Pompeu Fabra
Career Start Year 1988
Number of shared co-authors 1
Nanfang Hospital and Basic Medical College, Southern Medical University
Career Start Year 1987
Number of shared co-authors 2

Collaborators

Veracyte Inc.
Co-authored papers 19
GenomeDx Biosciences Inc.
Co-authored papers 11
University of British Columbia
Co-authored papers 8
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Co-authored papers 7
Northwestern University
Co-authored papers 7
Thomas Jefferson University Hospital
Co-authored papers 6
Cleveland Clinic
Co-authored papers 6
Northwestern University Feinberg School of Medicine
Co-authored papers 6
UCSF Medical Center-Mount Zion
Co-authored papers 5
Mayo Clinic
Co-authored papers 5
Johns Hopkins University School of Medicine
Co-authored papers 4
Johns Hopkins University School of Medicine
Co-authored papers 4
GenomeDx Biosciences Inc.
Co-authored papers 4
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 3
University of Miami Miller School of Medicine
Co-authored papers 3
GenomeDx Biosciences Inc.
Co-authored papers 3
Cedars-Sinai Medical Center
Co-authored papers 3
Department of Research and Development, Inc.
Co-authored papers 3
University of Utah
Co-authored papers 2
British Columbia Cancer Research Institute
Co-authored papers 2
University Health Network, University of Toronto
Co-authored papers 2
University of Toronto
Co-authored papers 2
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Center for Health Research, Kaiser Permanente Northwest Research Center
Co-authored papers 2
Center for Epigenetics, Van Andel Research Institute
Co-authored papers 2
GenomeDx Biosciences Inc.
Co-authored papers 2
Miller School of Medicine, University of Miami, Sylvester Comprehensive Cancer Center
Co-authored papers 2
university of california san diego School of Medicine
Co-authored papers 1
Mayo Clinic
Co-authored papers 1